Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMOD for oral lichen planus
IRCT138801191559N2Phase 3Completed
- Sponsor
- Pars Roos
- Start
- Nov 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of IMOD in oral lichen planus (OLP), sponsored by Pars Roos. Started Nov 2010; status: completed.
02
Drugs
IMOD
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on IRCT138801191559N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138801191559N2.